Arnuity Ellipta, Flonase Sensimist Relief, Avamys (fluticasone furoate) is a small molecule pharmaceutical. Fluticasone furoate was first approved as Arnuity Ellipta on 2008-01-11. It is used to treat allergic rhinitis perennial in the USA. It has been approved in Europe to treat allergic rhinitis perennial and allergic rhinitis seasonal. Breo ellipta's patents are valid until 2030-10-11 (FDA).
|Common Name||Fluticasone furoate|
|Indication||allergic rhinitis perennial, allergic rhinitis seasonal|